Taiwan FDA registration ca44b31d73ad12e6737bca156bb319fd
“Bisco” TheraCal PT Dual-Cured Resin-Modified Calcium Silicate Pulpotomy Treatment
TW: “畢斯寇”雙固化矽酸鈣襯底材
Taiwan·Risk Class 2·MD·BISCO, INC.·Registered Jan 20, 2022 – Jan 20, 2027ActiveRegistration details
- Analysis ID
- ca44b31d73ad12e6737bca156bb319fd
- License Form
- Ministry of Health Medical Device Import No. 035190
- Customs Code
- DHA05603519001
Company information
- Manufacturer
- BISCO, INC.
- Manufacturer Country
- United States
- Authorized Representative
- SHI SEI INTERNATIONAL LIMITED
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- F Dentistry
- Product Type (Level 2)
- F3250 Calcium hydroxide cavity substrate
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jan 20, 2022
- Expiry Date
- Jan 20, 2027
About this record
Access comprehensive regulatory information for “Bisco” TheraCal PT Dual-Cured Resin-Modified Calcium Silicate Pulpotomy Treatment in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ca44b31d73ad12e6737bca156bb319fd and manufactured by BISCO, INC.. The authorized representative in Taiwan is SHI SEI INTERNATIONAL LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices